X-linked myotubular myopathy
Living longer and awaiting treatment
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
The congenital myopathies (CMs) are a cluster of genetic disorders affecting myofiber structure and function. The salient clinical features are hypotonia, weakness, and motor impairment. The presentation varies from the most severe impairment in the newborn to a range of phenotypes in infancy (“floppy baby”), childhood, or occasionally adulthood. The prevalence of CMs is ≈1:26,000 children (birth to 17 years).1 The CMs were named on the basis of distinctive morphologic abnormalities seen on muscle biopsy: nemaline myopathy, with rods due to protein accumulation; core myopathy, with cores or multiminicores devoid of oxidative enzyme activity; centronuclear myopathy, with abnormal centrally placed nuclei; and congenital fiber-type disproportion, with a predominance of small type 1 fibers. Specific clinical features, e.g., ophthalmoparesis and facial, bulbar, and respiratory weakness, and muscle MRI can point toward a specific diagnosis.2 Standard-of-care guidelines for the CMs were published in 2012.3
Footnotes
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the editorial.
See page 1355
- © 2017 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Jeffrey Allen and Dr. Nicholas Purcell
► Watch
Related Articles
Alert Me
Recommended articles
-
Article
Phenotypes, genotypes, and prevalence of congenital myopathies older than 5 years in DenmarkNanna Witting, Ulla Werlauff, Morten Duno et al.Neurology: Genetics, March 21, 2017 -
Article
Congenital myopathiesNatural history of a large pediatric cohortIrene Colombo, Mariacristina Scoto, Adnan Y. Manzur et al.Neurology, November 26, 2014 -
Article
Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathyOzge Ceyhan-Birsoy, Pankaj B. Agrawal, Carlos Hidalgo et al.Neurology, August 23, 2013 -
Clinical/Scientific Notes
PHENOTYPE OF A PATIENT WITH RECESSIVE CENTRONUCLEAR MYOPATHY AND A NOVEL BIN1 MUTATIONK. G. Claeys, T. Maisonobe, J. Böhm et al.Neurology, February 08, 2010